Literature DB >> 33396614

Visceral Dissemination of Mucocutaneous Leishmaniasis in a Kidney Transplant Recipient.

Nídia Marques1, Manuela Bustorff1, Anabela Cordeiro Da Silva2,3, Ana Isabel Pinto2, Nuno Santarém2, Filipa Ferreira1, Ana Nunes1, Ana Cerqueira1, Ana Rocha1, Inês Ferreira1, Isabel Tavares1, Joana Santos1, Elsa Fonseca4, Conceição Moura4, André Cerejeira5, Júlia Vide5, Jorge Cancela6, Joana Sobrinho Simões7, Susana Sampaio1.   

Abstract

Intracellular protozoan of the genus Leishmania, endemic in the Mediterranean basin, are the cause of cutaneous (CL), mucocutaneous (MCL), and visceral leishmaniasis (VL). A 75-year-old woman was admitted nine years after a second kidney transplant (KT), due to persistent pancytopenia and fever. She presented edema and erythema of the nose in the last two years and an exophytic nodular lesion located on the left arm, with areas of peripheral necrosis and central ulceration in the last 18 months. A bone marrow biopsy revealed features compatible with Leishmania amastigotes, and polymerase chain reaction test (PCR) for Leishmania infantum was positive. Moreover, biopsy and PCR for L. infantum of the cutaneous lesion on the patient's left arm and nose and PCR from peripheral blood were positive. Thus, a diagnosis of CL, MCL, and VL was made, and liposomal amphotericin B was initiated, but the patient had an unfavorable outcome and died. This is the first report of a KT recipient presenting with the entire spectrum of leishmaniasis. In Portugal, this infection is rare-so a high degree of clinical suspicion is required for its diagnosis, especially in endemic regions, as visceral leishmaniasis is a potentially life-threatening infection.

Entities:  

Keywords:  immunosuppression; leishmaniasis; transplant

Year:  2020        PMID: 33396614      PMCID: PMC7824171          DOI: 10.3390/pathogens10010018

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  44 in total

1.  Presence of antibodies against Leishmania chagasi in haemodialysed patients.

Authors:  Roberto Mascarenhas Souza; Isaac Braullio Maia Delfino de Oliveira; Vinícius Câmara de Sousa Paiva; Kenio Costa Lima; Rivaldo Pereira dos Santos; José Bruno de Almeida; Kleber Giovanni Luz
Journal:  Trans R Soc Trop Med Hyg       Date:  2009-02-23       Impact factor: 2.184

2.  Risk factors, clinical features and outcomes of visceral leishmaniasis in solid-organ transplant recipients: a retrospective multicenter case-control study.

Authors:  W Clemente; E Vidal; E Girão; A S D Ramos; F Govedic; E Merino; P Muñoz; N Sabé; C Cervera; G F Cota; E Cordero; A Mena; M Montejo; F López-Medrano; J M Aguado; P Fernandes; M Valerio; J Carratalá; A Moreno; J Oliveira; P H O Mourão; J Torre-Cisneros
Journal:  Clin Microbiol Infect       Date:  2014-10-12       Impact factor: 8.067

Review 3.  [Epidemiology of leishmaniases in Portugal].

Authors:  Lenea Campino; Carla Maia
Journal:  Acta Med Port       Date:  2010-10-22

Review 4.  The biological diagnosis of leishmaniasis in HIV-infected patients.

Authors:  M Deniau; C Cañavate; F Faraut-Gambarelli; P Marty
Journal:  Ann Trop Med Parasitol       Date:  2003-10

5.  An approach for interlaboratory comparison of conventional and real-time PCR assays for diagnosis of human leishmaniasis.

Authors:  Israel Cruz; Aurélie Millet; Eugenia Carrillo; Mehdi Chenik; Poonam Salotra; Sandeep Verma; Nicolás Veland; Marlene Jara; Vanessa Adaui; Carlos Castrillón; Jorge Arévalo; Javier Moreno; Carmen Cañavate
Journal:  Exp Parasitol       Date:  2013-04-03       Impact factor: 2.011

6.  Clinical aspects of visceral leishmaniasis caused by L. infantum in adults. Ten years of experience of the largest outbreak in Europe: what have we learned?

Authors:  Luis Horrillo; Alicia Castro; Belén Matía; Laura Molina; Jesús García-Martínez; Jerónimo Jaqueti; Isabel García-Arata; Eugenia Carrillo; Javier Moreno; José Manuel Ruiz-Giardin; Juan San Martín
Journal:  Parasit Vectors       Date:  2019-07-24       Impact factor: 3.876

7.  Natural Resistance of Leishmania infantum to Miltefosine Contributes to the Low Efficacy in the Treatment of Visceral Leishmaniasis in Brazil.

Authors:  Juliana B T Carnielli; Renata Monti-Rocha; Dorcas Lamounier Costa; Aretha Molina Sesana; Laura N N Pansini; Marcela Segatto; Jeremy C Mottram; Carlos Henrique Nery Costa; Sílvio F G Carvalho; Reynaldo Dietze
Journal:  Am J Trop Med Hyg       Date:  2019-10       Impact factor: 2.345

8.  The Use of Specific Serological Biomarkers to Detect CaniLeish Vaccination in Dogs.

Authors:  Carla Lima; Nuno Santarém; Javier Nieto; Javier Moreno; Eugenia Carrillo; Daniella Castanheira Bartholomeu; Lilian Lacerda Bueno; Ricardo Fujiwara; Célia Amorim; Anabela Cordeiro-da-Silva
Journal:  Front Vet Sci       Date:  2019-10-24

Review 9.  New insights into leishmaniasis in the immunosuppressed.

Authors:  Hannah Akuffo; Carlos Costa; Johan van Griensven; Sakib Burza; Javier Moreno; Mercè Herrero
Journal:  PLoS Negl Trop Dis       Date:  2018-05-10

Review 10.  Place of Serology in the Diagnosis of Zoonotic Leishmaniases With a Focus on Visceral Leishmaniasis Due to Leishmania infantum.

Authors:  Maude F Lévêque; Laurence Lachaud; Loïc Simon; Emilie Battery; Pierre Marty; Christelle Pomares
Journal:  Front Cell Infect Microbiol       Date:  2020-02-25       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.